STK35 and colorectal carcinoma: NEDD4L can degrade serine/threonine kinase 35 (STK35) by ubiquitination and then inhibit glycolysis, increasing the apoptosis of CRC cells by suppressing the Akt signaling pathway and modulating the chemoresistance of CRC cells (42).